FDA emails show how vaccine leader questioned ‘hyper-accelerated’ 2021 review of Pfizer shot

The FDA’s top vaccine official raised concerns that a sharply accelerated process to review and formally approve Pfizer’s Covid-19 vaccine would undermine public confidence in the shots, leading to a series of vigorous exchanges between her and the agency’s senior leaders.

Phil Krause

The emails, contained…

Click here to view original post

Be the first to comment

Leave a Reply

Your email address will not be published.


*